InvestorsHub Logo
Followers 39
Posts 2716
Boards Moderated 0
Alias Born 02/08/2014

Re: HGilS post# 399530

Monday, 04/29/2024 9:56:50 AM

Monday, April 29, 2024 9:56:50 AM

Post# of 401950
That information is in the table at the bottom of the board....I"m thinking your just asking to get it posted and know it yourself? If not, wow, pay attention to the details of the OTC you invest in! The first two (filed earliest) are the ones that have passed their PDUFA date. I do not think they will necessarily be approved before the end of June. I think the FDA came back with questions and Nasrat had to look at everything going on and decide if pulling someone away from their day job or spending any more money to satisfy questions from FDA on po-dunk products was worth it. Other items Elite has going on that maybe more important includes:
- answering any questions related to Oxy and Vyvanse
- setting up new packaging facilities
- keep research/progress moving on new $billion dollar market products

Dopamine Agonist 12 M Filed with FDA - 22 Dec 2022 ---------- ----------
Antimetabolite 42 M Filed with FDA - 20 Apr 2023 ---------- ----------
Generic OxyContin 720 M Filed with FDA - 17 Aug 2023 ---------- ----------
Generic Vyvanse 5.1 B Filed with FDA - 21 Dec 2023 14 ----------

Want to add a "thank you!" the people/peoples that keep the table of products up to date. It is a very helpful resource that gives new and existing investors a quick overview of current and future potential.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News